NCT07750275Enrolling by invitation
Safety and Economics of Parenchymal Transection in Minimally Invasive Liver Surgery
Safety and Economics of Parenchymal Transection in Minimally Invasive Liver Surgery (LIVER-MIND 2): a Multicentre Retrospective Registry of the Italian Society of Endoscopic Surgery (SICE)
Source: ClinicalTrials.gov · Last updated 6 Aug 2026
Brief summary (registry, in English)
LIVER-MIND 2 is a multicentre, observational, retrospective registry coordinated by the SICE HPB and Minimally Invasive Surgery Working Group, enrolling consecutive adults undergoing elective minimally invasive (laparoscopic, robotic or hybrid) liver resection between January 2021 and December 2025 across ≥15 high-volume or dedicated centres (target \>30 centres).
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 800 (estimated)
- First submitted
- 20 Jul 2026
- Start date
- 1 Jan 2021
- Primary completion date
- Dec 2026
- Lead sponsor
- University of Molise
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT07750275
What you commit to
- Study type: Observational
- Planned participants: 800
- From 1 Jan 2021 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Urgent or emergency surgery
- Liver transplantation (donor / recipient)
- Associated major non-hepatic biliary or vascular resection
- Surgery before January 2021
Other
- Lack of consent or follow-up
- Participation in conflicting interventional trials
- Robotic procedures performed during the learning-curve phase (first 65 robotic cases per centre, per Rahimli et al.)
Who the study is looking for
- Age ≥ 18 years
- Elective minimally invasive liver resection
- Laparoscopic, robotic or hybrid approach
- Benign or malignant disease
- Signed informed consent for use of anonymised data
- Data completeness ≥ 70% in the CRF
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Molise Coordinator of this site? Confirm its status | Campobasso | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.